gamma-glutamyl-S-allylcysteine: has antiglycative activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 11346811 |
SCHEMBL ID | 1157668 |
MeSH ID | M000613292 |
Synonym |
---|
gamma-glutamyl-s-allylcysteine |
gamma-glutamyl-s-prop-2-en-1-ylcysteine |
unii-1o5qgm20nb |
glutamine, n-(2-(allylthio)-1-carboxyethyl)-, l- |
91216-95-4 |
gamma-glutamyl-s-2-propenylcysteine |
1o5qgm20nb , |
l-cysteine, l-gamma-glutamyl-s-2-propenyl- |
.gamma.-glutamyl-s-2-propenylcysteine |
.gamma.-glutamyl-s-prop-2-en-1-ylcysteine |
gamma-glutamyl- |
l-cysteine, l-.gamma.-glutamyl-s-2-propenyl- |
gamma-glutamyl- [usp-rs] |
.gamma.-glutamyl-s-allyl-l-cysteine (constituent of garlic) [dsc] |
.gamma.-glutamyl-s-allylcysteine |
glutamyl-s-allyl-l-cysteine, .gamma.-l- |
SCHEMBL1157668 |
(2s)-2-amino-5-[[(1r)-1-carboxy-2-prop-2-enylsulfanylethyl]amino]-5-oxopentanoic acid |
Q27252677 |
MS-24142 |
l-gamma-glutamyl-(s)-allyl-cysteine |
HY-N9413 |
CS-0160079 |
gamma-glutamyl-(usp-rs) |
gamma-glutamyl-s-allyl-l-cysteine (constituent of garlic) |
gsac dipeptide |
glutamyl-s-allyl-l-cysteine, gamma-l- |
(2s)-2-amino-4-{[(1r)-1-carboxy-2-(prop-2-en-1-ylsulfanyl)ethyl]carbamoyl}butanoic acid |
AKOS040758448 |
??-glutamyl-s-allylcysteine |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.67) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |